BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15347549)

  • 1. The effect of magnesium on length of stay for pediatric sickle cell pain crisis.
    Brousseau DC; Scott JP; Hillery CA; Panepinto JA
    Acad Emerg Med; 2004 Sep; 11(9):968-72. PubMed ID: 15347549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous magnesium sulfate for vaso-occlusive episodes in sickle cell disease.
    Goldman RD; Mounstephen W; Kirby-Allen M; Friedman JN
    Pediatrics; 2013 Dec; 132(6):e1634-41. PubMed ID: 24276838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children.
    Brousseau DC; Scott JP; Badaki-Makun O; Darbari DS; Chumpitazi CE; Airewele GE; Ellison AM; Smith-Whitley K; Mahajan P; Sarnaik SA; Casper TC; Cook LJ; Dean JM; Leonard J; Hulbert ML; Powell EC; Liem RI; Hickey R; Krishnamurti L; Hillery CA; Nimmer M; Panepinto JA;
    Blood; 2015 Oct; 126(14):1651-7. PubMed ID: 26232172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease.
    Griffin TC; McIntire D; Buchanan GR
    N Engl J Med; 1994 Mar; 330(11):733-7. PubMed ID: 8107739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
    Miner JR; Moore J; Gray RO; Skinner L; Biros MH
    Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Admission and length of stay due to painful vasoocclusive crisis in children.
    Rogovik AL; Li Y; Kirby MA; Friedman JN; Goldman RD
    Am J Emerg Med; 2009 Sep; 27(7):797-801. PubMed ID: 19683107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease.
    Panepinto JA; Brousseau DC; Hillery CA; Scott JP
    Pediatr Blood Cancer; 2005 Feb; 44(2):182-6. PubMed ID: 15390359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID; Woodward M; Reed GW
    Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing different patterns for managing febrile children in the ED between emergency and pediatric physicians: impact on patient outcome.
    Seow VK; Lin AC; Lin IY; Chen CC; Chen KC; Wang TL; Chong CF
    Am J Emerg Med; 2007 Nov; 25(9):1004-8. PubMed ID: 18022493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease.
    Raphael JL; Kamdar A; Wang T; Liu H; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Sep; 51(3):398-401. PubMed ID: 18300322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year review of hospital admissions among children with sickle cell disease in Kuwait.
    Akar NA; Adekile A
    Med Princ Pract; 2008; 17(5):404-8. PubMed ID: 18685282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalent lengths of stay of pediatric patients hospitalized in rural and nonrural hospitals.
    Lorch SA; Zhang X; Rosenbaum PR; Evan-Shoshan O; Silber JH
    Pediatrics; 2004 Oct; 114(4):e400-8. PubMed ID: 15466064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.
    Mathias MD; McCavit TL
    Pediatrics; 2015 Mar; 135(3):475-82. PubMed ID: 25667245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency department patient flow: the influence of hospital census variables on emergency department length of stay.
    Lucas R; Farley H; Twanmoh J; Urumov A; Olsen N; Evans B; Kabiri H
    Acad Emerg Med; 2009 Jul; 16(7):597-602. PubMed ID: 19438415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
    Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous dextrose during outpatient rehydration in pediatric gastroenteritis.
    Levy JA; Bachur RG
    Acad Emerg Med; 2007 Apr; 14(4):324-30. PubMed ID: 17296801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency department management of acute pain episodes in sickle cell disease.
    Tanabe P; Myers R; Zosel A; Brice J; Ansari AH; Evans J; Martinovich Z; Todd KH; Paice JA
    Acad Emerg Med; 2007 May; 14(5):419-25. PubMed ID: 17389246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obese patients with abdominal pain presenting to the emergency department do not require more time or resources for evaluation than nonobese patients.
    Platts-Mills TF; Burg MD; Snowden B
    Acad Emerg Med; 2005 Aug; 12(8):778-81. PubMed ID: 16079433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of an emergency department pain management protocol on the pattern of visits by patients with sickle cell disease.
    Givens M; Rutherford C; Joshi G; Delaney K
    J Emerg Med; 2007 Apr; 32(3):239-43. PubMed ID: 17394984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.